Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Health House is an Australian healthcare company focused on the commercial distribution of medicinal cannabis products and related patient access services. The business was founded to pursue opportunities in the medicinal cannabis market and was an early importer of medicinal cannabis into Australia. Historically, Health House operated as Health House International Limited, an ASX-listed distributor with activities across Australia and Europe, including the acquisition of Germany-based CanPharma. The current operating business appears to continue through HHI (Australia) Pty Ltd, which is now part of the Little Green Pharma Group. Its business centers on sourcing, importing, distributing, and supporting access to medicinal cannabis products rather than advancing a traditional drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health House.